Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms

Karina M Mata1, Cristiane Tefé-Silva1, Elaine M Floriano1

  • 1Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Abstract

Insights

Doxycycline pretreatment significantly reduced abdominal aortic aneurysm (AAA) development in rats by inhibiting matrix metalloproteinase (MMP) activity and inflammation. This suggests doxycycline

Area of Science:

  • Vascular Biology
  • Pharmacology

Background:

  • Abdominal aortic aneurysm (AAA) involves inflammation and extracellular matrix degradation by matrix metalloproteinases (MMPs).
  • Doxycycline is known to modulate MMP activity and influence AAA progression.

Purpose of the Study:

  • To investigate the effect of doxycycline pretreatment on AAA formation in a rat model.
  • To assess doxycycline's impact on MMP-2 and MMP-9 activity and inflammatory responses.

Main Methods:

  • Male Wistar rats were divided into aneurysm and control groups, with doxycycline pretreatment administered to respective subgroups.
  • AAA was induced via aortic wall injury and stenosis.
  • Morphological analyses, immunohistochemistry, and zymography were performed at various time points post-surgery.

Main Results:

  • Doxycycline treatment led to an 85% reduction in AAA development compared to untreated aneurysm groups.
  • A significant decrease in gelatinolytic activity of MMP-2 and MMP-9 was observed.
  • Reduced inflammatory responses were noted in doxycycline-treated animals.

Conclusions:

  • Doxycycline pretreatment effectively inhibits MMP-2 and MMP-9 activity.
  • This inhibition, along with reduced inflammation, suggests doxycycline's potential role in preventing AAA development.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
467
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
563
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
608
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
641
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.5K